Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Healthy Volunteers

Interventions

DRUG

Febuxostat XR

Febuxostat extended-release (XR) capsules

DRUG

Maalox Advance Regular Strength liquid

Maalox Advance Regular Strength liquid containing Aluminum Hydroxide 200 mg, Magnesium Hydroxide 200 mg, and Simethicone 20 mg/5 mL or equivalent

Trial Locations (1)

Austin